Biography
Holly Bowlin is Lead Counsel at Takeda where she is currently responsible for providing strategic advice to the Oncology Business Unit. She joined Takeda in June 2020 and currently serves as the lead legal advisor to the Data, Digital, & Technology team, U.S. Commercial Organization, U.S. Patient Services, and advises on life cycle management for global oncology brands. Ms. Bowlin is an experienced commercial attorney in the pharmaceutical space providing pragmatic and solutions-oriented advice to her business colleagues.
Prior to joining Takeda, Ms. Bowlin was Associate Director, Corporate Counsel at Sage Therapeutics, Inc., where she was responsible for advising on the build of the commercial organization and the launch of the company’s first-in-class product.